Navigation Links
Watson to Distribute Alendronate Tablets
Date:2/5/2008

CORONA, Calif., Feb. 5 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced today that the company expects to initiate shipments of alendronate sodium in the 35 and 70 mg once weekly dosage strengths when Fosamax(R) loses market exclusivity, which is anticipated to occur at the close of business on February 6, 2008. Alendronate sodium is the generic version of Merck's Fosamax(R) tablets, indicated for the treatment of osteoporosis in postmenopausal women. Alendronate sodium is also indicated to increase bone mass in men with osteoporosis.

Under the terms of a supply agreement, Merck will manufacture and supply the alendronate sodium tablets to Watson, which will market, sell and distribute the product in the United States. Merck will receive a share of the profits from Watson's sales of the generic product in the U.S. market. Further details on the agreement have not been disclosed.

About Watson Pharmaceuticals, Inc.

Watson Pharmaceuticals, Inc., headquartered in Corona, CA, is a leading specialty pharmaceutical company that develops, manufactures, markets, sells and distributes brand and generic pharmaceutical products. Watson pursues a growth strategy combining internal product development, strategic alliances and collaborations and synergistic acquisitions of products and businesses.

For press releases and other company information, visit Watson Pharmaceuticals' Web site at http://www.watson.com.

Forward-Looking Statement

Any statements contained in this press release that refer to future events or other non-historical facts are forward-looking statements that reflect Watson's c
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Watson Receives FDA Approval for Generic DuoNeb(R)
2. Watson Confirms Patent Litigation With Barr Related to Seasonale(R)
3. Barr Subsidiary Sues Watson and Sandoz for SEASONALE(R) Patent Infringement
4. Watson and Novartis Settle Lawsuit Over Exelon(R) Patent Litigation
5. Watson Names Mark Durand Chief Financial Officer
6. Watson Files FDA Application for Generic YAZ(R)
7. Texas Affiliates of Susan G. Komen for the Cure, Sen. Kirk Watson, Rep. Patrick Rose, Singer Kelly Willis, Breast Cancer Survivors and Activists Rally for Passage of Proposition 15
8. Watson Wyatt Identifies Major Benefit Trends During Open Enrollment Season
9. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
10. HealthCare.com & MediResource Partner to Distribute and License Health Content, Directory and Tools
11. CVS Caremark All Kids Can and Scholastic Distribute Free Educational Guides in Schools to Champion Acceptance and Build Self-Esteem among Second Graders

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)..., NEW YORK, Dec. 1 Reportlinker.... available in its catalogue: ,, The Future of ...ket Forecasts to 2015, Competitive Benchmarking, P...www.reportlinker.com/p0166814/The-Future-of-Centra...recasts-to-2015-Competitive-Benchmarking-Product-P...
(Date:12/1/2009)...CRAMENTO, Calif., Dec. 1 As health...ermanente is being hailed as a care delivery model...ducted today into The California Hall of Fame. Kai...ill accept the Spirit of California medal on his b...acramento this evening. ,, Kaiser,s greatest l...
(Date:12/1/2009)...research suggests that criteria based on computed ...colorectal liver metastases after chemotherapy wit...redict overall survival, according to a study in t...f bevacizumab to cytotoxic (toxic to cells) chemot...ients with stage IV colorectal cancer and higher p...
(Date:12/1/2009)... NEW ORLEANS, Dec. 1 Th...s largest professional association of blood specia...1st ASH Annual Meeting from December 5-8, 2009, at...eans, LA. The meeting will showcase the latest res...It is my pleasure to host ASH,s 51st annual meetin...
(Date:12/1/2009)...UTHFIELD, Mich., Dec. 1 ... ) ("First Mercury" or the "Company") announced to...rs declared a quarterly cash dividend of $0.025 pe...ers of record at the close of business on December...Corporation ,, First Mercury Financial Corpora...
Breaking Medicine News(10 mins):Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 2Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 3Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 4Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 5Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 6Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 7Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 8Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 9Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 10Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 11Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 12Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 13Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 14Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 15Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 16Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 17Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 18Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 19Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 20Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 21Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 22Health News:Health Care Pioneer Henry J. Kaiser Inducted Into The California Hall of Fame 2Health News:Health Care Pioneer Henry J. Kaiser Inducted Into The California Hall of Fame 3Health News:Criteria based on CT imaging after chemotherapy may help predict survival 2Health News:51st Annual Meeting of the American Society of Hematology Will Highlight Research and Policy Changes Affecting Medical Practice and Patient Care 2Health News:51st Annual Meeting of the American Society of Hematology Will Highlight Research and Policy Changes Affecting Medical Practice and Patient Care 3
...ucted by University of Denver (DU) Associate Profe...saging to get undergraduate students to wash their.... , In fall quarter 2007, researchers posted mess...ur hands," and contained vivid graphics and photos...
... Fast Radios, a leading provider of two way radi...Tekk International,s Tekk X1000 series radio as th...ot; , Naples, FL (PRWEB) ...0 series as the "Best New Two Way Radio Prod...
...thout parity insurance less likely to get timely o...hDay News) -- People whose insurance plans better ...vices use these programs more than those whose pla...ing and others whose plans put a greater cost burd...
...vices can significantly reduce the cost of prescri... care system, according to a new study by research...or every dollar spent by hospitals or health syste...savings, says Glen Schumock, associate professor a...
...prescription meds poses dangers, researchers say ,... many as 4 percent of older adults in the United S...escription drugs in ways that put them at risk for...tment visits for adverse drug reactions each year,...
...artment of Health and Human Services recently awar...Medal of Honor for achieving a lifesaving organ do...r a sustained 12-month period. The award was give...tal for Neuroscience work tirelessly to ensure the...
Other Medicine News:Health News:University of Denver uses 'gross' messaging to increases handwashing, fight Norovirus 2Health News:Fast Radios Names Tekk X1000 Best New Two-Way Radio Product 2Health News:Psych Patients With Cost-Sharing Plans Use More Services 2Health News:Drug Combinations Putting Seniors at Risk 2Health News:Drug Combinations Putting Seniors at Risk 3Health News:Drug Combinations Putting Seniors at Risk 4Health News:Jefferson Hospital for Neuroscience receives Department of Health and Human Services award 2
(Date:12/1/2009)... , NEW YORK, Dec. 1 Reportlinke...is available in its catalogue: ,, Contract Res...t Trends & Opportunities ,, http://www.re...ing-CRO---A-Global-Update-of-Market-Trends--Opport...(CRO), which came into being in the seventies, evo...
(Date:12/1/2009)... , CHERRY HILL, N.J., Dec. 1 /PRNewswire...is Bodine was surprised and delighted when his rad...ent from about 20 minutes each day to less than fi...rs at the Delaware Valley Urology Cancer Center ...therapy technology from Varian Medical Systems (N...
(Date:12/1/2009)... , INDIANAPOLIS, Dec. 1 /PRNewswire-... of Medicine, Improving Health... Improving Life,"...able at www.lillyforbetterhealth.com/value_of_med...t to providing "Answers That Matter" and encourage...s and the public about pharmaceutical industry pra...
Breaking Medicine Technology:Reportlinker Adds Contract Research Outsourcing (CRO) - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Contract Research Outsourcing (CRO) - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Contract Research Outsourcing (CRO) - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Contract Research Outsourcing (CRO) - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Contract Research Outsourcing (CRO) - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Contract Research Outsourcing (CRO) - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Contract Research Outsourcing (CRO) - A Global Update of Market Trends & Opportunities 8Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 2Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 3Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 4Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 5Lilly Releases Latest 'Value of Medicine' Resource Guide About Key Issues Facing the Pharmaceutical Industry 2Lilly Releases Latest 'Value of Medicine' Resource Guide About Key Issues Facing the Pharmaceutical Industry 3Lilly Releases Latest 'Value of Medicine' Resource Guide About Key Issues Facing the Pharmaceutical Industry 4URAC Stresses Importance of Standards for Wellness Programs and Health Plan at AHIP Institute 2009 49179 1URAC Stresses Importance of Standards for Wellness Programs and Health Plan at AHIP Institute 2009 49179 2URAC Stresses Importance of Standards for Wellness Programs and Health Plan at AHIP Institute 2009 49179 3China Biotics Inc to Join Russell 3000 Index 12669 1China Biotics Inc to Join Russell 3000 Index 12669 2China Biotics Inc to Join Russell 3000 Index 12669 37 Proven Steps 3A How to Defeat Stress Without Going Through the Embarrassment of Counseling 3A Proven Ways to Defeat Stress 49176 17 Proven Steps 3A How to Defeat Stress Without Going Through the Embarrassment of Counseling 3A Proven Ways to Defeat Stress 49176 27 Proven Steps 3A How to Defeat Stress Without Going Through the Embarrassment of Counseling 3A Proven Ways to Defeat Stress 49176 3
...-Related Effects For OROS(r),Methylphenidate , Two... OROS(r),Formulation , SAN DIEGO, CA, May 22, 2007... for parents and physicians who prescribe,medicati...der,(ADHD). Data presented on Tuesday at the 160th...ation highlighted findings that,long-acting OROS(r...
...ewswire-FirstCall/ -- Shire plc,announced today th...m), its Attention Deficit Hyperactivity Disorder (...the symptoms of ADHD in both,male and female child...l results reported at the American Psychiatric Ass... clinical studies have examined gender differences...
Other Medicine Technology:New Data Focuses on Abuse of Stimulant Medication 2New Data Focuses on Abuse of Stimulant Medication 3New Data Focuses on Abuse of Stimulant Medication 4New Data Focuses on Abuse of Stimulant Medication 5Daytrana (methylphenidate transdermal system) Provides Significant,Effectiveness in ADHD Symptom Relief in Both Boys and Girls 2Daytrana (methylphenidate transdermal system) Provides Significant,Effectiveness in ADHD Symptom Relief in Both Boys and Girls 3Daytrana (methylphenidate transdermal system) Provides Significant,Effectiveness in ADHD Symptom Relief in Both Boys and Girls 4Daytrana (methylphenidate transdermal system) Provides Significant,Effectiveness in ADHD Symptom Relief in Both Boys and Girls 5Daytrana (methylphenidate transdermal system) Provides Significant,Effectiveness in ADHD Symptom Relief in Both Boys and Girls 6Daytrana (methylphenidate transdermal system) Provides Significant,Effectiveness in ADHD Symptom Relief in Both Boys and Girls 7Daytrana (methylphenidate transdermal system) Provides Significant,Effectiveness in ADHD Symptom Relief in Both Boys and Girls 8
Akbarnia PDR
Spinal Instruments
Autologous Growth Factors
Leica D2D V3
Medicine Products: